Mount Sinai’s Emma Guttman, MD, PhD, Elected to the Association of American Physicians
Emma Guttman, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, has been elected to the Association of American Physicians (AAP). The prestigious honor recognizes top physician-scientists who exhibit excellence in the pursuit of medical knowledge and the advancement of basic or translational science through experimentation and discovery and their application to clinical medicine.
Dr. Guttman was formally introduced as a new member on Saturday, April 18, during a special dinner at the AAP’s annual meeting, held Friday, April 17, through Sunday, April 19, in Chicago.
“I am deeply honored to be elected to the Association of American Physicians, and I’m grateful to my colleagues, collaborators, and trainees. At Mount Sinai, we are building an integrated research and clinical ecosystem focused on redefining the treatment of inflammatory skin diseases,” said Dr. Guttman. “Together, we are advancing a broad portfolio of translational and clinical initiatives that are transforming how we treat inflammatory skin diseases, from pioneering new therapeutic targets to accelerating the development of next-generation treatments. We are committed to expanding treatment options and improving the lives of patients by bringing them meaningful, science-driven advances to care.”
Among many accomplishments, Dr. Guttman’s research has fundamentally reshaped the understanding and treatment of atopic dermatitis. Her translational has directly informed clinical trials and subsequent U.S. Food and Drug Administration approvals of new treatments. More recently, her research has expanded to additional conditions, including alopecia areata, scarring alopecia, and keloids, where she has identified new drug targets driving the development of next-generation therapies.
“Election to the Association of American Physicians is a significant honor that reflects Dr. Guttman’s extraordinary impact on the field of dermatology and immunology,” said Eric J. Nestler, MD, PhD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and Executive Vice President and Chief Scientific Officer of the Mount Sinai Health System. “Dr. Guttman’s pioneering work has transformed our understanding of inflammatory skin diseases and directly enabled the development of innovative therapies that are improving patient care. She exemplifies the very best of translational science.”
Founded in 1885, the Association of American Physicians is one of the nation’s oldest and most respected honorary medical societies. Election is limited to physicians with outstanding credentials in biomedical research and is considered one of the highest honors in academic medicine. The AAP includes approximately 1,200 active members and 700 emeritus and honorary members from the United States, Canada, and around the globe.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.
The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,700 clinical residents and fellows training throughout the Health System. The Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 4705 postdoctoral research fellows.
Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 90th percentile of U.S. private medical schools in Sponsored Programs Direct Expenditures per Principal Investigator, according to the Association of American Medical Colleges. More than 6,900 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.
